News

Zacks Investment Research on MSN2d
Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?
Novo Nordisk NVO is expected to beat estimates when it reports its first-quarter 2025 results before the opening bell on May ...
Nasdaq7d
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
Beyond diabetes and obesity, Novo Nordisk is diversifying its portfolio by developing Mim8 for hemophilia A, with plans to submit it for regulatory approval soon. Alhemo (concizumab) has been ...
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...
Nasdaq2d
Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?
Beyond diabetes and obesity, Novo Nordisk is diversifying its portfolio by developing Mim8 for hemophilia A, with plans to submit it for U.S. approval soon. Novo Nordisk and Lilly have both ...